Paysign PAYS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Other Revenue | $2.56M+1.6% | $2.52M+2.6% | $2.46M+12.5% | $2.19M+9.9% | $1.99M+7.4% | |
| Pharma Industry | $40.95M+20.8% | $33.89M+18.5% | $28.61M+19.4% | $23.96M+26.9% | $18.88M+49.2% | |
| Plasma Industry | $47.95M+5.1% | $45.62M+4.1% | $43.81M+3.4% | $42.39M-1.2% | $42.92M-2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Paysign break its business down?
- Paysign (PAYS) reports revenue by product across 3 parts — Other Revenue, Pharma Industry and Plasma Industry. Each is extracted from the segment footnotes and tracked over time.
- Where does Paysign's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Paysign's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
